DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,872,400 | +57221.8% | 66,135 | -39.8% | 0.27% | -47.6% |
Q1 2023 | $27,690 | +80.4% | 109,865 | +90.0% | 0.51% | +46.6% |
Q4 2022 | $15,350 | -98.9% | 57,833 | +963.7% | 0.35% | +929.4% |
Q3 2022 | $1,404,000 | -95.4% | 5,437 | -95.5% | 0.03% | -96.1% |
Q2 2022 | $30,363,000 | +120.8% | 119,766 | +155.4% | 0.87% | +159.4% |
Q1 2022 | $13,754,000 | +4500.0% | 46,888 | +5058.2% | 0.34% | +5483.3% |
Q4 2021 | $299,000 | -30.6% | 909 | -35.8% | 0.01% | -33.3% |
Q3 2021 | $431,000 | -98.3% | 1,416 | -98.5% | 0.01% | -98.3% |
Q2 2021 | $24,657,000 | +35.4% | 91,881 | +13.6% | 0.54% | +40.8% |
Q1 2021 | $18,209,000 | +32.6% | 80,899 | +30.8% | 0.39% | +29.0% |
Q4 2020 | $13,735,000 | +126.6% | 61,832 | +119.6% | 0.30% | +108.3% |
Q3 2020 | $6,062,000 | +21.8% | 28,152 | 0.0% | 0.14% | +25.2% |
Q2 2020 | $4,978,000 | +42.2% | 28,152 | +11.3% | 0.12% | +35.3% |
Q1 2020 | $3,500,000 | – | 25,285 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |